Clinical Trial Update: Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intravenous immunoglobulin for safety and efficacy in Japanese encephalitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Liverpool | Conditions: Japanese Encephalitis | Phase 2 | Status: COMPLETED